Huang F, Li K, Chen Z, Cui Z, et al. Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancer. Oncogene 2024 Nov 29. doi: 10.1038/s41388-024-03239.
PMID: 39613933